Search research articles
Contact Us
Filters
Showing results (441-450 of 751) with videos related to
Page
of 76
Sort By:
Clinical Chemistry
|
August 1, 1985
Which prostate antigen is which?
M C Wang, L A Valenzuela, G P Murphy, et al.
CA: a Cancer Journal for Clinicians
|
October 7, 1997
American Cancer Society guideline for the early detection of prostate cancer: update 1997
A von Eschenbach, R Ho, G P Murphy, et al.
Cancer
|
October 8, 1997
The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment
C J Mettlin, G P Murphy, M P Cunningham, et al.
The Tohoku Journal of Experimental Medicine
|
July 1, 1986
Evaluation of effect of treatment for primary lesions of stage D2 prostatic cancer by means of transrectal ultrasonotomography
H Ohe, H Watanabe, M Saitoh, et al.
Cancer
|
November 5, 1999
The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S
C J Mettlin, G P Murphy, C J McDonald, et al.
The Prostate
|
February 19, 2000
Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy
G P Murphy, A A Elgamal, M J Troychak, et al.
Investigative Urology
|
September 1, 1979
Purification of a human prostate specific antigen
M C Wang, L A Valenzuela, G P Murphy, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 24, 1970
Studies on the effects of procytoxide (PCO) on treated and untreated dog renal allografts
J H Groenewald, H D Brede, E A Mirand, et al.
Cancer
|
September 15, 1995
The National Cancer Data Base report on prostate cancer. American College of Surgeons Commission on Cancer and the American Cancer Society
C J Mettlin, G P Murphy, L S McGinnis, et al.
Journal of Medicine
|
January 1, 1971
Cardiodynamic and renal circulatory effects of P-286 in dogs
J L Evers, G H Hobika, J W Mostert, et al.
Page
of 76
Search research articles
Search
Showing results (441-450 of 751) with videos related to
Sort By:
Page
of 76
Clinical Chemistry
|
August 1, 1985
Which prostate antigen is which?
M C Wang, L A Valenzuela, G P Murphy, et al.
CA: a Cancer Journal for Clinicians
|
October 7, 1997
American Cancer Society guideline for the early detection of prostate cancer: update 1997
A von Eschenbach, R Ho, G P Murphy, et al.
Cancer
|
October 8, 1997
The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment
C J Mettlin, G P Murphy, M P Cunningham, et al.
The Tohoku Journal of Experimental Medicine
|
July 1, 1986
Evaluation of effect of treatment for primary lesions of stage D2 prostatic cancer by means of transrectal ultrasonotomography
H Ohe, H Watanabe, M Saitoh, et al.
Cancer
|
November 5, 1999
The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S
C J Mettlin, G P Murphy, C J McDonald, et al.
The Prostate
|
February 19, 2000
Follow-up ProstaScint scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy
G P Murphy, A A Elgamal, M J Troychak, et al.
Investigative Urology
|
September 1, 1979
Purification of a human prostate specific antigen
M C Wang, L A Valenzuela, G P Murphy, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 24, 1970
Studies on the effects of procytoxide (PCO) on treated and untreated dog renal allografts
J H Groenewald, H D Brede, E A Mirand, et al.
Cancer
|
September 15, 1995
The National Cancer Data Base report on prostate cancer. American College of Surgeons Commission on Cancer and the American Cancer Society
C J Mettlin, G P Murphy, L S McGinnis, et al.
Journal of Medicine
|
January 1, 1971
Cardiodynamic and renal circulatory effects of P-286 in dogs
J L Evers, G H Hobika, J W Mostert, et al.
Page
of 76